A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Butobarbital
Piperidolate
The risk or severity of adverse effects can be increased when Piperidolate is combined with Umeclidinium.
Butobarbital
Prifinium
The risk or severity of adverse effects can be increased when Prifinium is combined with Umeclidinium.
Butobarbital
Tropatepine
The risk or severity of adverse effects can be increased when Tropatepine is combined with Umeclidinium.
Butobarbital
Mebeverine
The risk or severity of adverse effects can be increased when Mebeverine is combined with Umeclidinium.
Butobarbital
Batefenterol
The risk or severity of adverse effects can be increased when Batefenterol is combined with Umeclidinium.
Butobarbital
Propiverine
The risk or severity of adverse effects can be increased when Propiverine is combined with Umeclidinium.
Butobarbital
Oxitropium
The risk or severity of adverse effects can be increased when Oxitropium is combined with Umeclidinium.
Butobarbital
Revefenacin
The risk or severity of adverse effects can be increased when Revefenacin is combined with Umeclidinium.
Butobarbital
Methscopolamine
The risk or severity of adverse effects can be increased when Methscopolamine is combined with Umeclidinium.
Butobarbital
Thonzylamine
The risk or severity of adverse effects can be increased when Thonzylamine is combined with Umeclidinium.
Butobarbital
Butylscopolamine
The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Umeclidinium.
Butobarbital
Imidafenacin
The risk or severity of adverse effects can be increased when Imidafenacin is combined with Umeclidinium.
Butobarbital
Dosulepin
The risk or severity of adverse effects can be increased when Dosulepin is combined with Umeclidinium.
Butobarbital
Trimebutine
The risk or severity of adverse effects can be increased when Trimebutine is combined with Umeclidinium.
Butobarbital
Benactyzine
The risk or severity of adverse effects can be increased when Benactyzine is combined with Umeclidinium.
Butobarbital
Dexetimide
The risk or severity of adverse effects can be increased when Dexetimide is combined with Umeclidinium.
Butobarbital
Dimetindene
The risk or severity of adverse effects can be increased when Dimetindene is combined with Umeclidinium.
Butobarbital
Hexocyclium
The risk or severity of adverse effects can be increased when Hexocyclium is combined with Umeclidinium.
Butobarbital
Pizotifen
The risk or severity of adverse effects can be increased when Pizotifen is combined with Umeclidinium.
Butobarbital
Mepenzolate
The risk or severity of adverse effects can be increased when Mepenzolate is combined with Umeclidinium.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3